Tel.:
+34 91 736 2385
LOCAL TIME
Contact:
Katarina Gluic
Hours:
Mon-Thu 8:30-17:00 Fri 8:30-15:00
16:19
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
52nd ERA-EDTA Congress
28-31 May 2015 London
About us
FAQs
Help Line
Personal Area
Homepage
Discussion forum -
52nd ERA-EDTA Congress
Topic -
C) Renal development and cystic diseases.
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
Thread / Poster
Author
Replies
Last reply
PERCUTANEOUS SCLEROTHERAPY VERSUS LAPAROSCOPIC CYST ABLATION FOR GIANT, SYMPTOMATIC RENAL CYSTS
Liliana Tuta
1
5/18/2015 9:27:00 PM
URINARY PROTEOMIC BIOMARKERS, A POWERFUL TOOL FOR PROGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PROGRESSION
Martin Pejchinovski
1
5/18/2015 9:14:00 PM
PKD1 AND PKD2 MUTATION ANALYSIS IN 90 UNRELATED ITALIAN PEDIGREES WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): SANGER SEQUENCING VS NEXT GENERATION SEQUENCING (NGS).
Sterpeta Diella
1
5/18/2015 3:59:00 PM
ADPKD IS A BARRIER TO EMPLOYMENT IN EUROPE
Andrew Makin
1
5/18/2015 12:54:00 PM
ADPKD DIAGNOSIS IN EUROPE: PATIENT REPORTS OF SYMPTOMS AT RECOGNITION AND POST DIAGNOSIS SUPPORT
Andrew Makin
1
5/18/2015 12:48:00 PM
Autosomal dominant polycystic kidney disease does not in itself appear to cause thrombocytopenia
Stella Setyapranata
1
5/17/2015 7:44:00 AM
BODY COMPOSITION MEASUREMENTS USING BIOIMPEDANCE ANALYSIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS TREATED WITH TOLVAPTAN.
MINORU MAKITA
1
5/16/2015 8:43:00 AM
HEMATURIA AND LOW BACK PAIN - THINK OF NUTCRACKER SYNDROME
Claudio Musetti
1
5/15/2015 6:12:00 PM
SERUM VITAMIN D LEVELS AND EXPRESSION OF VITAMIN D RECEPTOR (VDR) IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE(ADPKD).
Larissa Collis Vendramini
1
5/13/2015 6:19:00 PM
Does polyuria associated with vasopressin V2 receptor antagonismresult in an increased ureter diameter in ADPKD patients?
Niek Casteleijn
1
5/13/2015 11:09:00 AM
THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
SATORU MUTO
1
5/10/2015 10:02:00 AM
LONG-TERM RENAL OUTCOME OF A LARGE COHORT OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX
Djalila Mekahli
1
5/8/2015 7:42:00 PM
THE CARDIOVASCULAR EVENTS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS IN TAIWAN
Ping-Hsun Wu
1
4/17/2015 5:54:00 PM
Most viewed poster for this congress
Poster:
625
Visits:
3858
Title:
IS 4 CITRATE AN EFFECTIVE TOOL AS A CATHETER LOCKING SOLUTION?
Authors:
Joao Fazendeiro Matos ,
Centre:
Fresenius Medical Care | NephroCare Portugal
Poster most viewed in this topic
Poster:
58
Visits:
238
Title:
THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Authors:
SATORU MUTO ,
Centre:
Teikyo University
About us
Terms and Conditions
Special Access
Commercial Web Access
Follow us on: